$13.37
-0.35 (-2.55%)
Open$13.75
Previous Close$13.72
Day High$13.75
Day Low$13.04
52W High$15.15
52W Low$7.71
Volume—
Avg Volume73.7K
Market Cap88.43M
P/E Ratio—
EPS$-3.17
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+79.2% upside
Current
$13.37
$13.37
Target
$23.96
$23.96
$13.92
$23.96 avg
$25.97
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 127.54M | 122.60M | 46.50M |
| Net Income | -22,027,162 | -19,056,470 | 11.15M |
| Profit Margin | -17.3% | -16.4% | 24.0% |
| EBITDA | 3.97M | 3.62M | 17.15M |
| Free Cash Flow | — | — | 10.93M |
| Rev Growth | +4.0% | +4.0% | +24.8% |
| Debt/Equity | 0.32 | 0.32 | 0.73 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |